January 31, 2017 | Harrison Facebook Twitter LinkedInDigital Health Startup Makes Regular STD Testing More Accessible, Affordable, and Private AUSTIN, TX, January 24, 2017 — EverlyWell, a digital health startup transforming the consumer lab testing experience, today announced the launch of a new at-home STD test kit. The kit will help consumers screen for critical sexually transmitted diseases in the privacy of their own home with the same high accuracy as traditional lab tests. EverlyWell provides at-home lab testing kits with beautifully redesigned results. The platform empowers consumers to order, self-collect, and understand their own physician-approved lab tests with the goal of improving health, reducing risk of future or chronic disease, and preventing the spread of STIs and STDs. They are the only company offering a suite of regulatory-compliant, physician-authorized lab tests — now including STD testing — that can be ordered and collected by consumers without leaving home. “With STD rates reaching an all time record high in the United States, it’s important to us to help make STD testing a hassle free and frequent part of everyone’s sexual health,” said EverlyWell CEO and founder, Julia Cheek. “Consumers today want more information about their health without the cumbersome, time-consuming and confusing process of traditional lab testing, and today we’re excited to give people a consumer friendly option for discreet testing.” According to the latest STD surveillance report by the Centers for Disease Control, the rate of sexually transmitted diseases has been on a steady incline in recent years, according to data collected through 2014 — a statistic EverlyWell aims to change by making regular STD testing an easier and more discreet process than the standard lab visit. As with all of EverlyWell’s tests, the comprehensive STD test is taken in the privacy of the consumer’s own home and covers sexually transmitted diseases including: HIV, Hepatitis C, Syphilis, Herpes Type 2, Gonorrhea, Chlamydia, Trichomonas Vaginalis. EverlyWell is proud to be working with Molecular Testing Labs™, a leader in home-collection STD testing, to analyze the test samples. In the event that the test results are abnormal, a physician will contact the customer to discuss their particular case and prescribe medication where applicable within 24 hours. Male and female comprehensive kits are both priced at $249 and are covered by HSA or FSA accounts. The one-time price includes the physician follow up for consumers with abnormal results. EverlyWell has raised $3M to date and is on a multi-million dollar annual revenue trajectory within just a few months of their public launch at the TechCrunch Disrupt Battlefield Finals in September 2016. Since then, EverlyWell has grown at an impressive rate, acquiring 5,000 customers in less than 6 months. They have added two more certified partner labs, bringing the total to six, and will continue to announce additional tests, features and partnerships in early 2017. About EverlyWell EverlyWell provides at-home lab testing kits with beautifully redesigned results. The platform empowers consumers to order, self-collect, and understand their own physician-approved lab tests with the goal of improving health and reducing risk of future or chronic disease. The reports are clear and easy to follow, and include evidence-based insights and suggestions. Consumers can choose from custom panels, including: Cardiovascular, Fertility and Women’s Hormones, Heavy Metals, Metabolism, Men’s Health, Thyroid, Sleep & Stress, Food Sensitivity, Inflammation & Vitamin D, and Sexually Transmitted Diseases. Prices start at $79 and are covered by Flexible Spending and Health Savings Accounts. EverlyWell offers laboratory testing for wellness monitoring. The tests are not intended to diagnose or treat disease, or to substitute for a physician’s consultation. Find out more at EverlyWell.com, or follow us on Facebook or Twitter.